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Abstract 
Several studies suggest that the biological responses induced by manufactured 
nanoparticles (MNPs) may be linked to their accumulation within cells. However, MNP 
internalisation has not yet been sufficiently characterised. Therefore, the aim of this study 
was to compare the intracellular uptake of 3 different MNPs: two made of carbon black (CB) 
and one made of titanium dioxide (TiO2), in 16HBE bronchial epithelial cells and MRC5 
fibroblasts. Transmission electron microscopy was used to evaluate the intracellular 
accumulation. Different parameters were analysed following a time and dose-relationship: 
localisation of MNPs in cells, percentage of cells having accumulated MNPs, number of 
aggregated MNPs in cells, and the size of MNP aggregates in cells. The results showed that 
MNPs were widely and rapidly accumulated in 16HBE cells and MRC5 fibroblasts. Moreover, 
MNPs accumulated chiefly as aggregates in cytosolic vesicles and were absent from the 
mitochondria or nuclei. CB and TiO2 MNPs had similar accumulation patterns. However, TiO2 
aggregates had a higher size than CB aggregates. Intracellular MNP accumulation was 
dissociated from cytotoxicity. These results suggest that cellular uptake of MNPs is a 
common phenomenon occurring in various cell types. 
 
Keywords: nanotechnologies; nanomaterials; toxicity; lung 
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1. Introduction  
 Nanotechnology is an emerging field involving a wide range of technologies that 
measure, manipulate, or incorporate materials having at least one dimension between 1 and 
100 nanometers (ASTM International, 2006). Manufactured nanoparticles (MNPs) are 
intentionally produced for use in various consumer products or industrial techniques (e.g., as 
pigments or chemical catalysts). The properties of nanoparticles differ from those of bulk 
materials of the same compound, allowing them to exert novel physical and chemical 
functional activities (Lanone et al., 2006, 2009; Oberdörster et al., 2005a). 
 Although new applications of MNPs are generating considerable enthusiasm, there is 
increasing evidence that MNP exposure can lead to adverse health effects. The respiratory 
system is a major route of unintentional exposure to aerosolised MNPs. Moreover, the 
respiratory system is a potential route for MNP translocation to the systemic circulation. 
However, MNP translocation studies showed that this was a limited phenomenon, the 
pulmonary retention being more important (Kreyling et al., 2002). Therefore, MNP 
toxicological studies have been widely focused on the MNP fate in the pulmonary system. In 
vitro and in vivo studies established that MNP exposure can alter cell viability, induce 
inflammation and pulmonary tissue remodelling, and impair redox regulation (Donaldson et 
al., 2005; Stone et al., 2007). Furthermore, several studies suggest that the biological 
responses induced by MNPs may be linked to MNP accumulation within cells (Bartneck et 
al., 2010; Oh et al., 2010). Indeed, internalised MNPs may directly target organelles such as 
the mitochondria, leading to oxidative stress (Li et al., 2003; Oberdörster et al., 2005a). 
Another target of MNPs is the nucleus: thus, MNPs can directly or indirectly induce DNA 
oxidative damages in the nuclear compartment (Bhattacharya et al., 2009; Mroz et al., 2007; 
Trouiller et al., 2009). However, MNP internalisation has not yet been sufficiently 
characterised.    
 Various techniques have been used to study MNP internalisation. Flow cytometry or 
confocal microscopy was used in recent studies (Faklaris et al., 2008; Thurn et al., 2010). 
However, these techniques require MNP labeling or surface modification, which may 
constitute a major disadvantage given that changes in MNP physical characteristics (size, 
shape, surface chemistry) can modify the internalisation and/or subcellular localisation of 
MNPs (Al-Rawi et al., 2011; Gupta et al., 2005; Nativo et al., 2008; Win et al., 2005). 
Transmission electron microscopy (TEM) is the technique of reference for studying MNP 
internalisation. With TEM, nano-sized structures can be identified in the cell environment and 
within cellular organelles (Oberdörster et al., 2005b). However, TEM has rarely been used to 
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accurately quantify MNP internalisation. TEM evaluation of internalisation is a cumbersome 
and expensive procedure and requires optimal sample preparation (Schrand et al., 2010). To 
the best of our knowledge, no comparative TEM studies of the internalisation of various 
MNPs by various cell types are available. Moreover, the relationship between MNP 
internalisation and their physico-chemical characteristics has been insufficiently analysed.  
Therefore, the aim of this study was to use TEM to compare the intracellular uptake of 3 
well-characterized MNPs (one made of titanium dioxide and two of carbon black) in 2 
different relevant target cells (one representative of the bronchial epithelium, the other of the 
underlying connective tissue), according to MNP concentration and time of exposure. This 
comparison was supported by several parameters (localisation of aggregated MNPs in cells, 
percentage of cells having accumulated MNPs, number of aggregated MNPs in cells, size of 
MNP aggregates in cells analysed at different time points). Furthermore, we examined the 
effects of MNPs on cell viability. 
 We choose titanium dioxide (TiO2) and carbon black (CB) MNPs because TiO2 and 
CB nanoparticles are among the most widely produced nanomaterials (Baan et al., 2006). 
TiO2 in particles of supra-nanometer scale has been used commercially for over 100 years 
as a white pigment in numerous products including paints and other coatings, foods, 
cosmetics, and skin-care preparations such as topical sunscreens. Several newer 
technologies use TiO2 MNPs, for instance for producing paints and sunscreen lotions/sprays. 
CB MNPs are used chieftly as a pigment in inks and paints and in automobile tires 
(Donaldson et al., 2005; Ema et al., 2010).     
2. Material and methods 
2.1. Cellular models 
 MRC5 cells (ATCC CCL-171), a human fibroblast cell line, and the 16HBE14o- 
bronchial cell line (provided by Dr. D.C. Gruenert; Medical Research Facility, California 
Pacific Medical Centre, San Francisco, CA, USA) were used in this study. MRC5 cells were 
derived from normal lung tissue of a 14-week-old male foetus (Jacobs et al., 1970). The 
16HBE140- cell line was originally developed from human bronchial epithelium, transformed 
with SV40 large T-antigen (Cozens et al., 1994). Both cell lines were maintained in a culture 
medium (DMEM for MRC5 and DMEM/F12 for 16HBE14o-) with L-Glutamine supplemented 
with 10% foetal bovine serum (FBS) for MRC5 cells, 2% Ultroser G (UG) for 16HBE cells and 
1% antibiotics at 37°C in a 5%-CO2 humidified incubator. These cells were seeded at a 
density of 1 to 1.6 x 104cells.cm-². 
 5 
 
2.2. Manufactured nanoparticles 
 Three types of MNPs were tested: two made of CB (CB21 [P60] and CB13 [FW2] 
from Evonik/Degussa, Essen, Germany) and one of TiO2 (637254 from Sigma-Aldrich, Saint 
Louis, MO, USA). The mean aerodynamic diameters reported by the suppliers were 21 and 
13 nm for the CB21 and CB13 MNPs, respectively, and 15 nm for TiO2 MNPs.   
 Dry powders were used to evaluate the physico-chemical characteristics of MNPs. 
Specific surface area was measured at -196°C using the nitrogen absorption-desorption 
technique (Brunauer Emmet Teller method, BET). MNP granulometry and aggregation status 
were evaluated in particle suspensions using photon correlation spectroscopy (PCS) and 
zeta potential measurement, respectively (Zetasizer 300HS, Malvern Instruments, Malvern, 
UK).   
 Stock suspensions of MNPs were prepared by weighing out the dry powders and then 
suspending them in serum-free (0%) culture medium to reach the concentration of 2 mg.ml-1. 
The stock suspensions were stored at -20°C. Ten minutes before starting the experiments, 
we sonicated the defrosted MNP stock suspensions in an ultrasound bath to achieve optimal 
dispersion. We then diluted the suspensions in serum-free culture medium by successive 
dilutions. Cells were exposed to MNP concentrations of 0.5, 5 and 10 µg.cm-² (of cultured 
surface) for 6, 24 and 48 hours. Given that cells were cultured in 75 cm² flasks containing 15 
ml of DMEM, we needed suspensions to be diluted at the doses of 2.5, 25 and 50 µg.ml-1 
(corresponding to 0.5, 5 and 10 µg.cm-²). To do that, the stock suspensions were first diluted 
at 1: 4, then a second dilution (1: 10) was made from the new suspension to reach the 
concentration of 50 µg.ml-1 (or 10 µg.cm-²). Finally, the suspensions of 0.5 and 5 µg.cm-² (2.5, 
25 µg.ml-1) were done by diluting the 10 µg.cm-² MNP suspension.   
 MNP endotoxin content was measured using the Limulus Amebocyte Lysate (LAL) kit 
QCL-1000 (Lonza, Basel, Switzerland). Briefly, particles in DMEM were sonicated (as 
described above), and the particle suspensions were centrifuged for 10 min at 18,000g. The 
supernatants were collected and centrifuged. This sequence was repeated twice and the 
endotoxin levels in the supernatants were then determined. 
The main physico-chemical characteristics are summarized in Table 1. 
2.3. Cytotoxicity assay 
 Cytotoxicity was assessed using the colorimetric WST-1 assay (Roche Diagnostics, 
Rotkreuz, Switzerland), which measures the mitochondrial dehydrogenase activity in viable 
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cells. MRC5 and 16HBE cells were seeded in 96-well microplates at a density of 1.6 x 
104cells/cm² in DMEM containing 10% FBS or 2% UG, then left in the medium for 24h. 
Shortly before starting the exposures, 10 µg.cm-² of each MNP suspension were prepared as 
described above. However, since surfaces (0.32 cm²) and volumes (200 µl) in microplate 
wells were different from those in flasks, to expose cells to the same MNP concentration, the 
doses were adapted considering that 10 µg.cm-² corresponded to 16 µg.ml-1 of MNPs. After 
removing DMEM from wells and washing cells with 100µl/well of phosphate buffered saline 
(PBS), MNP suspensions were distributed in each well. After 24h of contact, MNP 
suspensions were removed and cells were washed with PBS. Then, cells were incubated 
with 100 µl/well of WST-1 solution for 2h, at 37°C, in the dark. Two hours later, the 
cytotoxicity was determined by measuring the absorbance with a scanning multi-well 
spectrophotometer (Multiskan Ex microplate photometer, ThermoFisher Scientific, Waltham, 
MA, USA). The absorbance directly correlates to the number of viable cells. Three 
independent experiments were performed with 3 replicate wells used for each condition in 
each experiment. 
2.4. Transmission electron microscopy 
2.4.1. Cell pellet fixation 
 Following exposure of cells to MNPs in flasks, attached cells were washed with 
culture media and fixed in situ with 2.5% glutaraldehyde in 0.045M sodium cacodylate buffer 
(pH 7.4) at 4°C for 2 hours. The cells were then washed 3 times in sodium cacodylate buffer. 
Once recovered by de-adhering with scrapers, cell suspensions in 0.045M sodium 
cacodylate buffer were centrifugated at 1500 rpm for 5-7 min, and the pellets were post-fixed 
with 2% osmium tetroxide in distilled water for 30 min, at room temperature and in the dark. 
2.4.2. Cell pellet embedding 
 The post-fixed pellets were dehydrated in graded ethanol series before being 
transferred into Beem capsules filled with epon resin (48.9%), dodecenyl succinic anhydride 
(17.9%) and nadic methyl anhydride (33.3%). Then, the capsules were incubated at 37°C, in 
an oven vacuum for 24h, followed by incubation in a 60°C oven for 24h, to complete the 
embedding. 
2.4.3. Sample ultrathin cuts and staining 
Ultrathin sections (60 nm thickness) were made with a Leika ultramicrotome and 
transferred without contrasting onto copper grids, they were observed with an analytical 
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transmission electron microscope (TEM).  
2.4.4. TEM evaluation 
 The microscope used for the study was a JEOL 1200 EX II TEM at 60kV (JEOL, 
Tokyo, Japan), fitted out with an energy dispersive X-ray spectrometer (EDS OXFORD LINK 
ISIS 300 spectrometer) and a digital GATAN camera (ERLANGSHEN ES500W). Observed 
MNPs were classified as aggregated within cells. We defined an MNP aggregate as a cluster 
of more than 1 MNP (Hackley, 2001).  
 Measurements were made on 50 morphologically preserved cells chosen randomly 
from 5 different grids in each condition. Observations were performed by 2 different 
observers, between whom agreement was greater than 95%. The following parameters were 
calculated using the SAISAM software (MicroVision, Evry, France): 
1. Cell localisation of MNPs (free in the cytoplasm or in vacuoles, mitochondria, or 
nuclei) 
2. Percentage of cells containing MNPs 
3. Mean number of aggregated MNPs in cells (per cell) 
4. Mean size of intracellular MNP aggregates (per cell) 
4.1. Mean size of each aggregate 
4.2. Percentage of cell surface area occupied by MNP aggregates 
 To improve the accuracy of our estimate of intracellular MNP accumulation, each cell 
displaying morphological signs of cellular death (cellular membrane disruption, cellular 
splitting/blebbing) was systematically excluded. Thus, only cells with visible and well 
preserved cytoplasm, nucleus, and mitochondria were studied. Furthermore, the chemical 
nature of TiO2 MNPs was checked using EDX analysis. Aggregated MNPs were classified 
based on their subcellular localisation (free in cytoplasm or in vacuoles, mitochondria, or 
nuclei). The time-response relationship was examined after 6, 24 and 48h exposure to 5 
µg.cm-2 and the dose-response relationship was investigated after 24h of contact to 0.5, 5 
and 10 µg.cm-2 of MNPs. 
2.5. Statistical analysis 
 Three independent experiments were performed by exposing the cells to the different 
MNPs at the different doses and during the different time periods. In the TEM studies, we 
analysed 50 cells of each experiment. We compared MNP accumulation across doses and 
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exposure times using the Chi-2 test and the other parameters using one-way ANOVA. When 
ANOVA showed statistically significant differences between treatments (p<0.05), pairwise 
comparisons were performed using Tukey’s test. The cellular viability data were compared by 
performing a Kruskal-Wallis test, followed by a Dunn’s test. All statistical analyses were 
conducted using GraphPad Prism software (GraphPad Software, Inc., La Jolla, CA, USA). 
p<0.05 was considered statistically significant. 
3. Results 
3.1. Physico-chemical characterisation of MNPs 
 Table 1 shows the physico-chemical characteristics of the MNPs. The 3 types of MNP 
had similar sizes and a round-like shape (L’Azou, 2008). Furthermore, CB13 MNPs had a 
significantly larger specific surface area than CB21 MNPs. The 3 MNPs shared a tendency to 
form aggregates of around 1 µm in the culture media, the CB21 aggregates being 
significantly larger than the TiO2 aggregates. No endotoxin contamination was detected in 
any of the three MNP samples.        
3.2. Cell localisation of MNP 
 Figures 1 and 2 show typical TEM images of MRC5 and 16HBE cells exposed to 5 
µg.cm-2 of CB13, CB21 or TiO2 MNP for 6 hours. The results of MRC5 exposure to 5 µg.cm
-² 
of MNPs are shown in figure 1. Panel A illustrates the CB13 MNP distribution in a MRC5 cell. 
CB13 MNPs were found as aggregates in the cytosol, usually in vesicle-like compartments 
and in rare instances free in the cytoplasm, being impossible to quantify such rare events. No 
particles were seen in the mitochondria, nuclei, or other organelles. Panels B and C of figure 
1 show CB21 and TiO2 MNP accumulation in the MRC5 cell line. Both MNP types were also 
found as aggregates in cytosolic vesicles. Panels A, B and C of figure 2 display the 
distributions of the 3 MNPs in 16HBE bronchial cells. As previously described in MRC5 cells, 
each MNP type was usually seen as aggregates in cytoplasmic vesicles and less often 
visualised free in the cytosol. Again, no MNPs were found in mitochondria or nuclei.  
3.3. Percentage of cells containing MNPs 
 Figure 3 shows the percentages of the 2 cell lines containing the three MNPs.  
Time-response relationship 
 About 60% of MRC5 cells contained CB13 MNPs after 6h (Fig. 3A). This percentage 
increased to nearly 80% after 24h (p<0.05 vs. 6h) then remained stable until 48h. Moreover, 
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the percentage of cells containing TiO2 and CB21 MNPs also increased significantly over 
time.  
 Almost 95% of 16HBE cells accumulated CB13 MNPs after 6h and this value did not 
change over 24 and 48h (Fig. 3B). An absence of time-response effect was also observed 
with TiO2 MNPs. Moreover, the percentage of cells containing MNPs after 6h was 
significantly lower with TiO2 and CB21 MNPs than with CB13 MNPs (p<0.05).  
 Finally, with 16HBE cells, the percentage of cells containing CB13 and CB21 MNPs at 
6h was significantly higher than MRC5 cells (p<0.05).  
Dose response relationship 
 About 60% of MRC5 cells contained CB13 MNPs after exposure to 0.5 µg.cm-2 (Fig. 
3C). This percentage increased to near 80% when cells were exposed to 5 µg.cm-2 (p<0.05 
vs. 0.5 µg.cm-2) and no further increase was observed after exposure to 10 µg.cm-2. Similar 
results were obtained with CB21 MNPs. A slightly different response was observed after 
exposure to TiO2 MNPs, since the percentage increased significantly after exposure to 5 
µg.cm-2 compared to 0.5 µg.cm-2 and then decreased when a dose of 10 µg.cm-2 was used.  
 Almost 80% of 16HBE cells accumulated CB13 MNPs after exposure to 0.5 µg.cm-2 
and this value did not change when doses of 5 and 10 µg.cm-2 were used (Fig. 3D). A similar 
response was observed with TiO2 MNPs. However, with CB21 MNPs, the percentage of cells 
containing MNPs increased dose-dependently between 5 and 10 µg.cm-2 (p<0.05 in both 
cases). Moreover, the percentage of cells containing MNPs after exposure to 0.5 µg.cm-2  
was significantly lower with TiO2 and CB21 MNPs than with CB13 MNPs (p<0.05). 
 No significant difference in the dose-response effect was found between the 2 cell 
lines, except for CB13 accumulation that seemed to occur in more 16HBE cells with the 
lowest dose. 
 Overall, these results show time- and dose-dependent modulations in the percentage 
of MRC5 cells containing the three MNPs. These modifications were not found consistently 
with 16HBE cells. 
3.4. Mean number of aggregated MNPs in cells  
 Figure 4 shows the average number of aggregated MNPs observed in both cell lines. 
Indeed, as accumulated MNPs were found chiefly as aggregates in both cell types, we 
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therefore counted only MNP aggregates.  
Time-response relationship 
 With MRC5 cells, we found a time-dependent increase in the number of CB13 MNP 
aggregates but not in the number of CB21 and TiO2 MNPs (Fig. 4A). By contrast, a time-
dependent modification in the number CB21 and TiO2 MNPs aggregates was observed in 
16HBE cells (Fig. 4B). In neither cell type were there any major differences across the 3 
MNP types. Finally, differences were found between the MNP aggregate numbers in 16HBE 
and MRC5 cells after 6h but not after 24h or 48h. 
Dose response relationship 
 A dose-response effect was observed for the 3 MNPs in MRC5 cells (Fig. 4C). With 
16HBE cells, a dose-response effect was noted only with TiO2 MNPs (Fig. 4D).  Finally, 
16HBE cells contained larger aggregate numbers of CB13 and CB21 MNPs at 0.5 µg.cm-2 
than did MRC5 cells (p<0.05).  
3.5. Mean size of intracellular MNP aggregates  
3.5.1. Mean size of individual aggregates (Fig. 5).  
 Figure 5 shows the mean size of individual MNP aggregates observed in both cell 
lines. As we performed these observations by TEM, a two-dimensional technique, the 
aggregate size was expressed as a surface (µm²).  
Time-response relationship 
 In MRC5 cells, the mean size of individual CB13 and CB21 MNP aggregates 
increased transiently at 24h (Fig. 5A). After 6h, the mean size was significantly greater for 
TiO2 MNP aggregates than for CB13 and CB21 MNP aggregates (6 fold increase, p<0.05 for 
both comparisons) and did not change significantly over time. A similar general pattern was 
observed in 16HBE cells (Fig. 5B) except that the transient increase was noted only with 
TiO2 MNPs. No major differences were found between the 2 cell lines.   
Dose response relationship 
 The size of MNP aggregates showed no major dose-dependency with either cell line 
(Fig. 5C and 5D). In both cell lines, the size with exposure to 0.5 µg.cm-² was higher with 
TiO2 MNPs than with the other 2 MNPs (p<0.05 for both comparisons). The size was greater 
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in 16HBE cells than in MRC5 cells.  
3.5.2. Percentage of cell surface area occupied by MNP aggregates (Fig. 6).  
 As compared to the size of individuals MNP aggregates, similar time- and dose-
dependencies of aggregate size were obtained when the results were expressed as the 
percentage of the cell surface area occupied by MNP aggregates on TEM sections (Fig. 6).  
3.6. Cytotoxicity of MNPs in MRC5 and 16HBE cell lines 
 Figure 7 shows the percentage of viable MRC5 and 16HBE cells after 24h exposure 
to each MNP in a dose of 10 µg.cm-².  
 After 24h of exposure to 10 µg.cm-² of CB13 MNPs, the percentage of viable MRC5 
cells decreased significantly to about 30%. No changes in 16HBE cell viability were noted 
under the same conditions. Furthermore, the viability of MRC5 and 16HBE cells did not 
change after exposure to CB21 and TiO2 MNPs.  
4. Discussion 
 The main results of our study are as follows: 1) MNP accumulation occurred in a high 
percentage of cells overall (60-80%), was close to the peak value after only 6h, and occurred 
even with the lowest dose of 0.5 µg.cm-²; 2) MNPs accumulated chiefly as aggregates in 
cytosolic vesicles, and the number of aggregates increased over time or with the dose, 
except with CB MNPs in 16HBE cells whose aggregate number was at the peak after 6h 
(CB13) or with the lowest dose studied (CB13 and CB21); and 3) with the shortest exposures 
and lowest doses, the size was higher overall for TiO2 MNP aggregates than for the 2 CB 
MNP aggregates. Although several statistically significant differences between the 2 cell lines 
were found, these differences were quantitatively minor, indicating that the behaviour of the 2 
cell lines was similar overall after exposure to all 3 MNP types. Thus, intracellular MNP 
accumulation seems to be a common and rapid phenomenon that occurs in both epithelial 
and mesenchymal cells. However, the chemical nature of the MNPs influences intracellular 
accumulation. Thus, compared to the 2 CB MNP types, TiO2 MNPs had a larger mean 
aggregate size within cells and a smaller specific surface area and aggregate size in the 
culture media (Table 1). Finally, MNP accumulation was dissociated from cellular toxicity. 
Indeed, CB13 was the only cytotoxic MNP type, and this cytotoxicity occurred only with the 
MRC5 cells.  
 The first aim of the study was to compare MNP accumulation in different cell types. 
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Since the respiratory system is a major route of MNP entry into the body, we used 16HBE 
and MRC5 cells as models of the bronchial epithelium and subjacent connective tissue, 
respectively. It is reasonable to use TEM to confirm cellular uptake of MNPs, TEM being a 
good qualitative method to analyse particle uptake. However, because any TEM picture is 
only reflecting one plane of cells, this technique is considered at most as a semiquantitative 
method to determine the MNP distribution in a whole cell. Therefore, to obtain reproducible 
and representative results, 50 cells on several different fields were observed and each entire 
cell was examined. In both cell types, MNPs accumulated rapidly, in more than half the 
cultured cells, but occupied a small percentage of the cell surface area (between 0.04 and 
4%). Furthermore, in both cell types, invaginations of the plasmic membrane were observed 
and MNPs were found chiefly as aggregates located in cytosolic vesicles. These 
observations suggest an endocytosis-mediated mechanism of internalisation, as described 
previously (Faklaris et al., 2009; Saxena et al., 2008; Singh et al., 2007; Stearns et al., 2001; 
Thurn et al., 2010). In these studies, various endocytic pathways have been suspected to be 
involved in MNP accumulation (e.g., macropinocytosis, clathrin-mediated endocytosis, or 
caveolae-mediated endocytosis). The results showed that macropinocytosis seemed to be 
the principal mechanism of MNP uptake. Our observations are in agreement with these 
results. Indeed, membrane invaginations and cytoplasmic vesicles are signs of an endocytic 
mechanism. Moreover, Hussain and coworkers showed that macropynocitosis was involved 
in 16HBE internalisation of the same CB MNP than those used in the present study (Hussain 
et al., 2009). We did not find MNPs in the mitochondria or nuclei, in agreement with studies 
by Xia et al. (2006) and Bhattacharya et al. (2009). However, in other studies that used 
primary human monocyte macrophages or mesenchymal stem cells, MNPs were found in 
these compartments (Hackenberg et al., 2011; Porter et al., 2006), suggesting that the site of 
accumulation may depend on the MNP type and/or cell type. Overall, the data reported here 
suggest that MNPs may accumulate similarly in lung epithelial cells and fibroblasts.  
 We evaluated the influence of MNP physico-chemical characteristics on intracellular 
accumulation. We focused on MNP with a narrow range of diameters (13-21 nm), but 
differences in chemical composition (TiO2 vs. CB), and specific surface area (CB13 vs. 
CB21). Both TiO2 and CB MNPs accumulated rapidly, in keeping with earlier studies in 
several lung models showing accumulation after only 6h (Geiser et al., 2005; Stearns et al., 
2001). For example, a flow cytometry study reported in 2011 showed that internalisation of 
SiO2 MNPs measuring 50 to 300 nm by the alveolar epithelial cell line A549 cells occurred 
chiefly within the first 2 hours and reached a plateau after 6 hours (Shapero et al., 2011). The 
percentage of cells containing MNPs was similar with the 3 MNP types, all of which were 
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visible as aggregates surrounded by a membrane, and, rarely, as isolated particles. 
Aggregates may reflect internalisation of isolated MNPs and/or of MNP aggregates. The 
granulometric evaluation of MNPs in the culture media strongly supports the second 
possibility, since all 3 MNP types were detected as aggregates measuring about 1 µm in 
diameter. Furthermore, it has been shown that non-phagocytic cells internalise MNP 
aggregates more easily than isolated MNPs (Andersson et al., 2011; Hackenberg et al., 
2011). Therefore, the cells probably internalised the MNPs chiefly as aggregates. The mean 
size of MNP aggregate within cells, as determined using TEM to evaluate sections, seemed 
to be smaller (about 0.1µm²) than the mean diameter of aggregates in culture medium, as 
determined using PCS. If the particles have a round-like shape, then the aggregate size in 
the culture medium should be greater than 0.8µm², and MRC5 and 16HBE cells may unable 
to internalize the largest aggregates. However, these considerations must be viewed with 
caution because we compared a measured aggregate size within cells (obtained using TEM) 
to a calculated aggregate size in the culture medium. Overall, our results suggest that the 
chemical nature and specific surface area of the 3 MNPs influenced neither the kinetics of 
MNP internalisation nor the percentage of cells containing accumulated MNPs. Furthermore, 
all 3 MNP were found as aggregates within cells.  
 Internalised TiO2 MNPs behaved differently from accumulated CB MNPs. Thus, the 
size of intracellular TiO2 MNP aggregates was higher overall than that of the CB MNP 
aggregates. This different was seen with both cell types, starting at 6h and with the lowest 
dosages. This result suggests that TiO2 MNPs may penetrate the cell and accumulate in a 
single vesicle that is constantly full. Pan et al. (2009) obtained similar results using primary 
dermal fibroblasts incubated with rutile TiO2 MNPs. However, they also observed that 
anatase particles produced huge holes in the cell cytoplasm, a finding not replicated in our 
study. MNP size was similar in the study by Pan et al. (2009) and in our study, but the 
discrepancy may be related to other differences in the experimental conditions (e.g., 
presence vs. absence of serum in the culture media with the MNPs and primary vs. 
fibroblastic cell line). Since the 3 MNPs used in our study were closely similar in size and 
shape, these 2 parameters were probably not involved in the difference between TiO2 and 
CB MNPs. A role for the specific surface area of the MNPs (Hsiao et al., 2011; Yue et al., 
2010) is unlikely since this parameter was similar for the TiO2 and CB21 MNPs. Furthermore, 
specific surface area was greater for the CB13 MNPs than for the CB21 MNPs, whereas the 
size of the intracellular aggregates was similar for these 2 MNPs. The chemical nature of the 
MNPs may affect the capacity for aggregation, leading to differences in intracellular 
behaviour. There is evidence that TiO2 MNPs form aggregates easily and rapidly in 
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(hydrophilic) polar environments such as culture media (Geiser et al., 2005). The zeta 
potential data showing that TiO2 MNPs in DMEM had the lowest aggregation capacity and 
the smaller size of the TiO2 MNP aggregates compared to the CB21 MNP aggregates argue 
against this possibility. Another possibility is disaggregation of CB MNPs within cells, leading 
to a smaller size compared to TiO2 MNP aggregates. Although data supporting this 
hypothesis was observed in MRC5 cells between 24 and 48h (fig. 5A), a similar phenomenon 
was observed concerning TiO2 aggregates, thus ruling out this hypothesis. Further work is 
needed to explain the difference in aggregate size between TiO2 MNPs and CB MNPs. 
 We evaluated MNP cytotoxicity by performing the WST-1 assay on MNP-exposed 
cells. Of the 3 MNP types, only CB13 induced a decrease in MRC5 cellular viability. None of 
the 3 MNP types affected the viability of 16HBE cells. These results suggest that 1) 
internalised MNPs do not always exert cytotoxic effects such as those described in murine 
macrophages  exposed to gold nanoparticles (Zhang et al., 2010), and that 2) the biological 
responses induced by MNP depend on the cell type. Inversely, we demonstrated previously 
that carbon nanotubes induced cytotoxicity in epithelial cells in the absence of internalisation 
(Tabet et al., 2009). The relationship between intracellular accumulation and cellular 
responses such as inflammation remains to be investigated. Another remarkable fact is that 
CB13 MNPs, the only cytotoxic particles in our study, also had the highest specific surface 
area. This parameter seems to play a crucial role in the biological effects of CB13 MNPs. In 
vivo and in vitro biological responses such as oxidative stress or inflammation correlate 
closely with the specific surface area of particles such as CB or silica (Brown et al., 2001; 
Hussain et al., 2009; Stoeger et al., 2006; Waters et al., 2009). However, this parameter was 
unrelated to accumulation in our study, emphasising the complexity of MNP effects on cells. 
5. Conclusion 
 In conclusion, we showed that MNPs were widely and rapidly internalised by 
bronchial cells and pulmonary fibroblasts. In both cell types, MNPs accumulated as 
aggregates in cytosolic vesicles and were absent from the mitochondria or nuclei. MNP 
accumulation was rapid, and dependent on exposure time or concentration. Overall, CB and 
TiO2 MNP had similar accumulation patterns, although TiO2 aggregates had a higher size 
than CB aggregates. Intracellular MNP accumulation was dissociated from cytotoxicity. 
These results shed new light on the interactions between MNPs and cells and indicate that 
internalisation is a relatively stereotyped cellular response to MNP exposure, at least in non-
phagocytic cells. 
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Tables 
 
 
 
Table 1. Physico-chemical characterisation of manufactured nanoparticles.  
Zeta potential and granulometry were evaluated in DMEM without foetal bovine serum. 
Corresponding data are presented as the mean ± SEM. * Significantly different compared to 
CB21 (p<0.05). nd = not detected.  
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Figure Legends 
 
Fig. 1. Transmission electron microscopy views of MRC5 cells incubated with 5 µg.cm-2 of 
manufactured nanoparticles (MNPs) for 6 hours. (A) Typical MRC5 cell with CB13 MNPs 
within a vesicle (scale bars: 2 µm on the left, 0.5 µm on the right). (B) CB21 MNPs being 
internalised by a MRC5 cell (scale bars: 5 µm on the left, 0.5 µm on the right). (C) MRC5 cell 
with TiO2 MNPs in a vesicle (scale bars: 5 µm on the left, 0.5 µm on the right).  
Fig. 2. Transmission electron microscopy views of 16HBE cells incubated with 5 µg.cm-2 of 
manufactured nanoparticles (MNPs) for 6 hours. (A) Typical 16HBE cell with CB13 MNPs in 
a vesicle (scale bars: 10 µm on the left, 0.5 µm on the right). (B) 16HBE cell with a vesicle 
containing CB21 MNPs (scale bars: 5 µm on the left, 0.5 µm on the right). (C) 16HBE cell 
with TiO2 MNPs in a vesicle (scale bars: 2 µm on the left, 0.5 µm on the right).  
Fig. 3. Percentage of cells containing manufactured nanoparticles (MNPs). (A) MRC5 cells 
incubated with 5 µg.cm-2 of MNPs for 6h, 24h, or 48h. (B) 16HBE cells incubated with           
5 µg.cm-2 of MNPs for 6h, 24h or, 48h. (C) MRC5 cells incubated for 24h with 0.5, 5, or       
10 µg.cm-2 of MNPs. (D) 16HBE cells incubated for 24h with 0.5, 5 or 10 µg.cm-2 of MNPs. 
The Figure displays the results of one representative experiment (N = 50 cells) of 3 
independent experiments. * Significant difference across MNP types (p < 0.05). # Significant 
difference between cell types (p < 0.05). Y axis: percentage of cells containing MNPs.  
Fig. 4. Number of manufactured nanoparticles (MNPs) in cells. (A) MRC5 cells incubated 
with 5 µg.cm-2 of MNPs for 6h, 24h, or 48h. (B) 16HBE cells incubated with 5 µg.cm-2 of 
MNPs for 6h, 24h, or 48h. (C) MRC5 cells incubated for 24h with 0.5, 5 or 10 µg.cm-2 of 
MNPs. (D) 16HBE cells incubated for 24h with 0.5, 5 or 10 µg.cm-2 of MNPs. The Figure 
displays the results of one representative experiment (N = 30-40 cells) of 3 independent 
experiments.  Data are mean ± SEM. * Significant difference across MNP types (p < 0.05).   
# Significant difference between cell types (p < 0.05). Y axis: number of MNPs in cells. 
Fig. 5. Mean size of individual manufactured nanoparticles (MNPs) aggregates in cells.      
(A) MRC5 cells incubated with 5 µg.cm-2 of MNPs for 6h, 24h, or 48h. (B) 16HBE cells 
incubated with 5 µg.cm-2 of MNPs for 6h, 24h or 48h. (C) MRC5 cells incubated for 24h with 
0.5, 5 or 10 µg.cm-2 of MNPs. (D) 16HBE cells incubated for 24h with 0.5, 5 or 10 µg.cm-2 of 
MNPs. The Figure displays the results of one representative experiment (N = 30-40 cells) of 
3 independent experiments. Data are mean ± SEM. * Significant difference across MNPs     
(p < 0.05). # Significant difference between cell types (p < 0.05). Y axis: mean size of 
individual MNP aggregates (µm²). 
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Fig. 6. Percentage of cell surface area occupied by manufactured nanoparticles (MNPs) 
aggregates. (A) MRC5 cells incubated with 5 µg.cm-2 of MNPs for 6h, 24h or 48h.               
(B) 16HBE cells incubated with 5 µg.cm-2 of MNPs for 6h, 24h or 48 hours. (C) MRC5 cells 
incubated for 24h with 0.5, 5 or 10 µg.cm-2 of MNPs. (D) 16HBE cells incubated for 24h with 
0.5, 5 or 10 µg.cm-2 of MNPs. The Figure displays the results of one representative 
experiment (N = 30-40 cells) of 3 independent experiments.. Data are mean ± SEM.               
* Significant difference across MNP types (p < 0.05). # Significant difference between cell 
types (p < 0.05). Y axis: percentage of cell surface area occupied by MNP aggregates. 
Fig. 7. Cytotoxicity of manufactured nanoparticles (MNPs) in MRC5 and 16HBE cells. Cells 
were exposed to 10 µg.cm-² of MNPs for 24 h. Cell viability was measured using the WST-1 
assay. Data are the percentages of surviving cells relative to the control reported as the 
mean ± SEM of three independent experiments. * Significantly different from control             
(p < 0.05). 
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